SEC Comment Letter 0000000000-24-014139 to Organogenesis Holdings Inc. (ORGO) (CIK 0001661181) (ORGO)
Organogenesis Holdings Inc. (ORGO) (CIK 0001661181)
Date: Dec. 20, 2024 · CIK: 0001661181 · Accession: 0000000000-24-014139
AI Filing Summary & Sentiment
File numbers found in text: 333-283934
Letter
December 20, 2024 Gary Gillheeney Chief Executive Officer Organogenesis Holdings Inc. 85 Dan Road Canton, MA 02021 Re:Organogenesis Holdings Inc. Registration Statement on Form S-3 Filed December 19, 2024 File No. 333-283934 Dear Gary Gillheeney: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Ryan M. Rourke Reed
Show Raw Text
December 20, 2024
Gary Gillheeney
Chief Executive Officer
Organogenesis Holdings Inc.
85 Dan Road
Canton, MA 02021
Re:Organogenesis Holdings Inc.
Registration Statement on Form S-3
Filed December 19, 2024
File No. 333-283934
Dear Gary Gillheeney:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Ryan M. Rourke Reed